Newsfeeds - Spark Newswire

1 minute read

News

Horizon Therapeutics Announced New Analysis Of MRI Findings Show UPLIZNA Reduced The Formation of Asymptomatic Optic Nerve Lesions In People With Neuromyelitis Optica Spectrum Disorder

Today, 7:12 AM

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new MRI imaging data from the Phase 3 clinical trial showing UPLIZNA reduced the formation of subclinical (asymptomatic) optic nerve lesions in people with NMOSD.

HZNP

2 minute read

Horizon Therapeutics’ Debt Overview

By Benzinga Insights

Today, 7:12 AM

Over the past three months, shares of Horizon Therapeutics Inc. (NASDAQ:HZNP) increased by 13.37%. When understanding a companies…

HZNP

1 minute read

Here’s How Much You Would Have Made Owning Horizon Therapeutics Stock In The Last 5 Years

By Benzinga Insights

Today, 7:12 AM

Horizon Therapeutics (NASDAQ:HZNP) has outperformed the market over the past 5 years by 40.09% on an annualized basis…

HZNP

1 minute read

Horizon Therapeutics Q4 Adjusted EPS $1.21 Beats $1.09 Estimate, Sales $942.00M Beat $922.92M Estimate

By Benzinga Newsdesk

Today, 7:12 AM

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.09 by 11.01 percent. This is a 14.18 percent decrease over earnings of $1.41 per share

HZNP

11 minute read

Earnings

Earnings Scheduled For March 1, 2023

By Benzinga Insights

Today, 7:12 AM

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

AAN

1 minute read

Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline

By Vandana Singh

Today, 7:12 AM

Amgen Inc’s (NASDAQ:AMGN) fourth-quarter revenues were $6.84 billion, beating the consensus of $6.76 billion, largely unchanged from Q4 2021, and…

ABBV

1 minute read

Analyst Says Selecta Biosciences’ Gout Candidate Can Potentially Raise The Bar On Several Fronts

By Vandana Singh

Today, 7:12 AM

Canaccord Genuity has increased the price target for Selecta Biosciences Inc (NASDAQ:SELB) from $9 to $10 while maintaining the Buy rating ahead of…

ALPMF

1 minute read

U.S. Senator Elizabeth Warren Writes FTC To Express Concern About Two Pharmaceutical Deals; Warren Tells Agency She Is “Particularly Concerned” About Amgen Plan To Buy Horizon Therapeutics And Indivior’s Plan To Buy Opiant Pharmaceuticals

By Benzinga Newsdesk

Today, 7:12 AM

- Reuters

AMGN

1 minute read

Horizon Therapeutics Touts Positive Data From Mid-Stage Study For Immune System Disorder

By Vandana Singh

Today, 7:12 AM

Horizon Therapeutics plc’s (NASDAQ:HZNP) Phase 2 trial evaluating dazodalibep for Sjögren’s syndrome met its primary endpoint in the second patient…

HZNP

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 7:12 AM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ALGN